50% Dextrose Injection Shortage

• • 50% Dextrose intravenous injection, Amphastar, 50 mL Luer-Jet syringe, 10 count, NDC 76329-3302-01
  • 50% Dextrose intravenous injection, Pfizer, 50 mL LifeShield syringe, 10 count, NDC 00409-4902-34
  • 50% Dextrose intravenous injection, Pfizer, 50 mL Ansyr II Luer Lock syringe, 10 count, NDC 00409-7517-16
  • 50% Dextrose intravenous injection, Pfizer, 50 mL vial, 25 count, NDC 00409-6648-02

• • Amphastar has 50% dextrose on shortage due to increased demand.
  • Pfizer has 50% dextrose on shortage due to manufacturing delays.

• • There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Amphastar has 50% dextrose 50 mL syringes on allocation.
  • Pfizer has 50% dextrose 50 mL Ansyr II syringes, 50 mL LifeShield syringes, and 50 mL vials are on back order and the company estimates a release date of April 2024 for the 50 mL Ansyr syringes and 50 mL vials and June 2024 for the 50 mL LifeShield syringes.